scholarly journals Effect of Toxoplasma gondii on Some Physiological Indicators in Women's Patients with Diabetic Mellitus Type 2

2021 ◽  
pp. 61-65
Author(s):  
Sukayna Jabbar Mushattat ◽  
Nawras Noori Beshboosh ◽  
Adhraa Baqir Hassan
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Toxoplasma Gondii ◽  
Venous Blood ◽  
Diabetic Patients ◽  
Diabetic Mellitus ◽  
Blood Samples ◽  
And Control

Aims: Diabetes mellitus is thought to be caused by infection with the parasite Toxoplasma gondii, although this is still debated, In order to better understand the potential link between toxoplasmosis and diabetes mellitus Study Design: China's prevalence rate of diabetes has been gradually growing in recent years, as a result of the country's rising living standards. Place and Duration of Study: 40 patients who suffer from type 2 diabetes mellitus who were randomly chosen from the Diabetes Mellitus clinic in Al-Sadder Teaching City in Al-Najaf governorate. Methodology: Prior research "on the link between T. gondii infection and diabetes mellitus has been conflicting, we performed matched case-control studies to see whether T. gondii seropositivity is linked" to type 2 diabetes, more research is required. To investigate T. gondii seroprevalence and recognize risk factors and potential transmital pathways of T. gondii infection in type 2 diabetes (T2DM), forty women's blood samples have been gathered and tested for anti-T. gondii IgG, IgM, and SOD. T. gondii seroprevalence in T2DM patients as a whole. Patients' information was collected through a questionnaire that included their age, weight, and blood pressure. Each patient and control participant had five milliliters of venous blood samples collected using a disposable needle and plastic syringes. Results:  Patients ranged in age about from (35 to 65) years old. The current investigation was performed on 40 patients who suffer from type 2 diabetes mellitus, Diabetic and T. gondii patientshad a significantly higher compared with control and Diabetic patients only. Also, there were significant differences between patients of diabetic mellitus and control. Conclusion: Blood was permitted to clot for 10 minutes at room temperature before being centrifuged at 6000 rpm for 10 minutes, after which serum was extracted and transferred into fresh disposable tubes. An ELISA test was performed on the blood samples earlier using commercially available kits (EIA-3519 IgG and IgM Germany) and SOD kits.

scholarly journals α-2-Macroglobulin in Saliva Is Associated with Glycemic Control in Patients with Type 2 Diabetes Mellitus

2015 ◽  
Vol 2015 ◽  
pp. 1-5 ◽  
Author(s):  
Juan Pablo Aitken ◽  
Carolina Ortiz ◽  
Irene Morales-Bozo ◽  
Gonzalo Rojas-Alcayaga ◽  
Mauricio Baeza ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Glycemic Control ◽  
Control Group ◽  
Diabetic Patients ◽  
Promising Alternative ◽  
Positive Discrimination ◽  
And Control

Background. Subjects with type 2 diabetes mellitus (DM2) require an adequate glycemic control to avoid diabetic complications. Currently, saliva biomarkers are used as a diagnostic tool and can be indicative of the degree of progression and control of various diseases. Several studies indicate thatα-2-macroglobulin levels are elevated in diabetic patients.Methods. 120 subjects with DM2 were enrolled and classified into two groups according to their glycemic control (percentage of glycated hemoglobin-A1c (HbA1c), <7% adequate glycemic control group; >7% inadequate glycemic control group). The relationship betweenα-2-macroglobulin levels from saliva samples and HbA1c was subsequently evaluated.Results. We found a positive correlation betweenα-2-macroglobulin and HbA1c (r=0.778andP<0.0001). Area under the receivers operating characteristic (ROC) curve ofα-2-macroglobulin indicated a positive discrimination threshold ofα-2-macroglobulin (AUC = 0.903, CI 95%: 0.847–0.959,P<0.0001) to diagnose glycemic control.Conclusions. Our data strongly suggest that the level of salivaα-2-macroglobulin is an indicator for the degree of glycemic control in diabetic patients and represents a promising alternative method to evaluate this parameter.

scholarly journals A STUDY OF LIPID PROFILE IN DIABETES MELLITUS TYPE-2 PATIENTS

2021 ◽  
Vol 5 (11) ◽  
Author(s):  
Vipin Kumar ◽  
Maya Pensiya ◽  
V B Singh
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Lipid Profile ◽  
Diabetic Patients ◽  
Cross Sectional ◽  
Significant Difference ◽  
Sugar Levels ◽  
And Control

Background: To study the lipid profile in diabetes mellitus in type 2 Diabetes mellitus patients. Methods: This is a cross sectional case control study. 100 patients of type 2 diabetes mellitus and 100 age and sex matched healthy controls were taken. Lipid profile were done in cases and controls using appropriate tests. Results: The fasting blood sugar levels in all the diabetics were significantly higher as compare to control. There was significant difference in mean HDL, Triglycerides level in diabetic and control patients. There was no significant difference in LDL, Cholesterol level in Diabetic and control patients. Conclusion: We concluded that there is a high prevalence of elevated lipid levels among the diabetic patients. Keywords: Diabetes Mellitus -2, Cholesterol, Lipid Profile

scholarly journals Cell-free long non-coding RNA-H19 and miRNA-29a, miRNA-29b expression in Type 2 Diabetes Mellitus patients.

2020 ◽  
Author(s):  
Mohammed Alfaifi ◽  
Amit Kumar Verma ◽  
Mohammed Yahya Alshahrani ◽  
Prakash C Joshi ◽  
Ali Gaithan Alkhathami ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Weight Loss ◽  
Type 2 Diabetes Mellitus ◽  
Blood Glucose ◽  
Diabetic Patients ◽  
Subjective Data ◽  
Blood Samples ◽  
Clinicopathological Findings

Abstract Background: Type 2 diabetes mellitus [T2DM] has been one of the common diseases and characterized by increased blood glucose levels. T2DM participates in several organ damages as well revealed that cell-free non-coding RNAs and microRNAs (miRNAs) have been demonstrated to serve as important diagnostic/prognostic biomarkers in the pathophysiology of diabetes.Materials/Methods: The present study included clinically confirmed untreated newly diagnosed 200 cases of T2DM and 200 healthy subjects. Blood samples collected in fluoride vials were used to check blood glucose for fasting and after 2 hours of breakfast (postprandial), blood samples collected in EDTA vials used for the Hba1c level.Blood samples from all the participants were collected in plain vials used for cell-free total RNA extraction. Total extracted RNA was quantified and 100ng was used to synthesized the cDNA for cell-free lncRNA H19, miRNA-29a, and miRNA-29b expression using specific primers/ probes using quantitative real-time PCR method. Serum Biochemical parameters were analyzed after collection of the sample to observe the changes among T2DM cases and healthy controls. Subjective data were recorded to evaluate the association with lncRNA H19, miRNA-29a, and miRNA-29b expression among T2DM cases. Results: It was observed that type 2 diabetic patients had decreased [0.59 fold] lncRNA H19 expression while increased miRNA-29a [5.62 fold] and miRNA-29b [5.58 fold] expression. Decreased expression of lncRNA H19 was observed to be associated with gender [p=0.004], hypertension [p<0.0001], weight loss [p=0.02] and fatigue [p=0.02]. Increased miRNA29a expression was linked with hypertension [p<0.0001], alcoholism [p=0.04], and smoking [p<0.0001] as well as miRNA-29b expression was associated with hypertension [p=0.0001], weight loss [p=0.002], smoking [p=0.0002], alcoholism [p<0.0001]. Low [<1 fold] and high [>1 fold] expression of lncRNA H19 expression was linked with miRNA-29a [p=0.005] and miRNA-29b [p<0.0001] expression. lncRNA H19 expression showed negative correlation with miRNA-29a expression [r= -27, p<0.0001] and miRNA-29b [r= -47, p<0.0001]. Conclusion: The present study concluded that lower lncRNA H19 expression, and increased miRNA-29b, miRNA-29b expression associated with the severity of T2DM patients. Decreased lncRNA H19 expression, and increased miRNA-29b, miRNA-29b expression observed to be interrelated with clinicopathological findings of T2DM patients could involve in pathogenesis disease.

scholarly journals Assessment of Nerve Conduction Study and Electroencephalogram Abnormalities in Type 2 Diabetes Mellitus

2016 ◽  
Vol 23 (2) ◽  
pp. 159-168 ◽  
Author(s):  
Farah N. Abass ◽  
Moshtak Abdul-Atheem ◽  
Hanan F. Aswad
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Peripheral Neuropathy ◽  
Nerve Conduction Study ◽  
Nerve Conduction ◽  
Diabetic Patients ◽  
Control Subjects ◽  
And Control

AbstractBackground and aims: This study aims to evaluate the electroencephalographic and nerve conduction changes in type 2 diabetes mellitus (T2DM) patients with and without peripheral neuropathy (DPN) and to investigate the relationship with other variables such as age, gender, duration of the diabetes and the degree of metabolic control.Materials and methods: This was a cross-sectional study, including 100 patients with T2DM and 100 control subjects, aged 34 to 77 years. All patients enrolled in the study were subjected to full assessment, including: history, biochemical and electrophysiological tests.Results: The study found that patients with diabetic peripheral neuropathy (DPN) in comparison to patients without DPN and control subjects were older, had longer duration of diabetes and poorer glycemic control reflected by fasting blood glucose and glycated hemoglobin. The electrophysiological findings showed that patients with DPN have significant differences in nerve conduction study (NCS) parameters when compared to patients without DPN and control subjects in the form of axonal degeneration and demyelination. They also had abnormalities of the electroencephalogram (EEG) which are correlated with nerve conduction study severity.Conclusion: Routine NCS is an important method for evaluating DPN. Investigating sensory nerves of lower limbs is helpful in discovering the early stages of DPN when other tested nerves are normal. The F-wave can be used as a sensitive indicator for the early diagnosis of DPN and it can help to detect the subclinical lesions. EEG examination in diabetic patients with severe DPN is important in showing the defect in the central nervous system.

Association of Major Dietary Patterns with General and Abdominal Obesity in Iranian Patients with Type 2 Diabetes Mellitus

2015 ◽  
Vol 85 (3-4) ◽  
pp. 145-155 ◽  
Author(s):  
Marjan Ghane Basiri ◽  
Gity Sotoudeh ◽  
Mahmood Djalali ◽  
Mohammad Reza Eshraghian ◽  
Neda Noorshahi ◽  
...  
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Abdominal Obesity ◽  
Dietary Patterns ◽  
Dietary Pattern ◽  
Diabetic Patients ◽  
General Obesity ◽  
Healthy Dietary Pattern

Abstract. Background: The aim of this study was to identify dietary patterns associated with general and abdominal obesity in type 2 diabetic patients. Methods: We included 728 patients (35 - 65 years) with type 2 diabetes mellitus in this cross-sectional study. The usual dietary intake of individuals over 1 year was collected using a validated semi-quantitative food frequency questionnaire. Weight, height, and waist circumference were measured according to standard protocol. Results: The two major dietary patterns identified by factor analysis were healthy and unhealthy dietary patterns. After adjustment for potential confounders, subjects in the highest quintile of the healthy dietary pattern scores had a lower odds ratio for the general obesity when compared to the lowest quintile (OR = 0.45, 95 % CI = 0.26 - 0.79, P for trend = 0.02), while patients in the highest quintile of the unhealthy dietary pattern scores had greater odds for the general obesity (OR = 3.2, 95 % CI = 1.8 - 5.9, P for trend < 0.001). There were no significant associations between major dietary patterns and abdominal obesity, even after adjusting for confounding factors. Conclusion: This study shows that in patients with type 2 diabetes mellitus, a healthy dietary pattern is inversely associated and an unhealthy dietary pattern is directly associated with general obesity.

ESTIMATION OF SERUM FERRITIN LEVELS IN TYPE 2 DIABETIC PATIENTS AND ITS RELATION WITH HbA1C LEVEL.

2019 ◽  
Vol 3 (8) ◽  
Author(s):  
Shah Namrata Vinubhai ◽  
Pardeep Agarwal ◽  
Bushra Fiza ◽  
Ramkishan Jat
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Blood Sugar ◽  
Serum Ferritin ◽  
Inflammatory Marker ◽  
Control Group ◽  
Diabetic Patients ◽  
Positive Correlation

Background: Serum ferritin is known as an index for body iron stores also as an inflammatory marker and it is influenced by several disease. We were looking for a correlation between HbA1c and S. Ferritin in type 2 DM. Methodology: The present study a total of 150 participants were enrolled of which 100 were confirmed cases of Type 2 Diabetes Mellitus and rest 50 age and sex matched healthy subjects constituted the control group. All were screened for HbA1c, Fasting blood sugar, Post prandial blood sugar and S.Ferritin. Results: A highly significant variation and positive correlation was observed with respect to S.Ferritin and HbA1c levels. Mean S.Ferritin was high in the subgroup with poor glycemic control. Conclusion: The fasting, post prandial sugar levels, HbA1c and S.Ferritin were significantly higher in the diabetic subjects. This study shows a positive correlation between HbA1c and S. Ferritin levels. So we can conclude that in diabetic patients S. Ferritin may serve as an independent marker of poor glycemic and metabolic control. Keywords: Serum ferritin, Type 2 Diabetes Mellitus, HbA1c.

Epidemiology of Hypertension and Diabetes Mellitus in Latin America

2020 ◽  
Vol 16 ◽  
Author(s):  
Patricio Lopez-Jaramillo ◽  
Jose Lopez-Lopez ◽  
Daniel Cohen ◽  
Natalia Alarcon-Ariza ◽  
Margarita Mogollon-Zehr
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Latin America ◽  
Cardiovascular Diseases ◽  
Latin American ◽  
Premature Mortality ◽  
Increased Risk ◽  
And Control

: Hypertension and type 2 diabetes mellitus are two important risk factors that contribute to cardiovascular diseases worldwide. In Latin America hypertension prevalence varies from 30 to 50%. Moreover, the proportion of awareness, treatment and control of hypertension is very low. The prevalence of type 2 diabetes mellitus varies from 8 to 13% and near to 40% are unaware of their condition. In addition, the prevalence of prediabetes varies from 6 to 14% and this condition has been also associated with increased risk of cardiovascular diseases. The principal factors linked to a higher risk of hypertension in Latin America are increased adiposity, low muscle strength, unhealthy diet, low physical activity and low education. Besides being chronic conditions, leading causes of cardiovascular mortality, both hypertension and type 2 diabetes mellitus represent a substantial cost for the weak health systems of Latin American countries. Therefore, is necessary to implement and reinforce public health programs to improve awareness, treatment and control of hypertension and type 2 diabetes mellitus, in order to reach the mandate of the Unit Nations of decrease the premature mortality for CVD.

scholarly journals A Narrative Review on Sarcopenia in Type 2 Diabetes Mellitus: Prevalence and Associated Factors

Nutrients ◽  
2021 ◽  
Vol 13 (1) ◽  
pp. 183
Author(s):  
Anna Izzo ◽  
Elena Massimino ◽  
Gabriele Riccardi ◽  
Giuseppe Della Pepa
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Elderly Population ◽  
The Elderly ◽  
Narrative Review ◽  
Macrovascular Complications ◽  
Diabetic Patients ◽  
Age Related

Type 2 diabetes mellitus (T2DM) represents a major health burden for the elderly population, affecting approximately 25% of people over the age of 65 years. This percentage is expected to increase dramatically in the next decades in relation to the increased longevity of the population observed in recent years. Beyond microvascular and macrovascular complications, sarcopenia has been described as a new diabetes complication in the elderly population. Increasing attention has been paid by researchers and clinicians to this age-related condition—characterized by loss of skeletal muscle mass together with the loss of muscle power and function—in individuals with T2DM; this is due to the heavy impact that sarcopenia may have on physical and psychosocial health of diabetic patients, thus affecting their quality of life. The aim of this narrative review is to provide an update on: (1) the risk of sarcopenia in individuals with T2DM, and (2) its association with relevant features of patients with T2DM such as age, gender, body mass index, disease duration, glycemic control, presence of microvascular or macrovascular complications, nutritional status, and glucose-lowering drugs. From a clinical point of view, it is necessary to improve the ability of physicians and dietitians to recognize early sarcopenia and its risk factors in patients with T2DM in order to make appropriate therapeutic approaches able to prevent and treat this condition.

Sign in / Sign up

Export Citation Format

Share Document